Heywood Group

Dr Heywood is a GOSH BRC Principal Research Fellow and group leader in Translational Mass Spectrometry.  She is also an Honorary Clinical Biochemist at Great Ormond Street Hospital and the UCLH National Hospital and Director and co-founder of the UCL spin out Guilford Street Laboratories.

The Heywood research group focuses on Lysosomal Storage Disorders developing biomarkers in Neuronal Ceroid Lipofuscinosis (Battens disease), Niemann Pick C disease and the Glycosphingolipidoses disorders (Fabry, Gaucher & Krabbe disease). They have a specific interest in the toxic mechanisms of lyso-lipids.

With expertise in proteomics and lipidomics for biomarker discovery and understanding disease mechanisms the group develops novel targeted multiplex assay panels for clinical applications such as clinical trials and development of novel therapies. This includes the creation of the Immuno TADA platform an innovative multiplex antibody assay now in commercial development to be offered through the NHS. The group has particular focus on supporting active collaborations with clinical partners to develop and streamline translation of novel biomarkers.